Edwards Lifesciences Corp
NYSE:EW
Edwards Lifesciences Corp
NYSE:EW
Price:
88.14 USD
0.52%
Market Closed
Updated:
Jun 8, 2024
Edwards Lifesciences Corp
Additional Paid In Capital
|
Edwards Lifesciences Corp
Additional Paid In Capital Peer Comparison
Comparables:
BSX
SYK
ABT
ISRG
SWAV
Competitive Additional Paid In Capital Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Additional Paid In Capital | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Edwards Lifesciences Corp
NYSE:EW
|
Additional Paid In Capital
$2.4B
|
CAGR 3-Years
17%
|
CAGR 5-Years
10%
|
CAGR 10-Years
13%
|
|
|
Boston Scientific Corp
NYSE:BSX
|
Additional Paid In Capital
$20.7B
|
CAGR 3-Years
2%
|
CAGR 5-Years
4%
|
CAGR 10-Years
2%
|
|
|
Stryker Corp
NYSE:SYK
|
Additional Paid In Capital
$2.3B
|
CAGR 3-Years
8%
|
CAGR 5-Years
8%
|
CAGR 10-Years
7%
|
|
|
Abbott Laboratories
NYSE:ABT
|
Additional Paid In Capital
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
Additional Paid In Capital
$8.9B
|
CAGR 3-Years
10%
|
CAGR 5-Years
11%
|
CAGR 10-Years
13%
|
|
|
Shockwave Medical Inc
NASDAQ:SWAV
|
Additional Paid In Capital
$586m
|
CAGR 3-Years
8%
|
CAGR 5-Years
17%
|
CAGR 10-Years
N/A
|
See Also
What is Edwards Lifesciences Corp's Additional Paid In Capital?
Additional Paid In Capital
2.4B
USD
2.4B
USD
Based on the financial report for Mar 31, 2024, Edwards Lifesciences Corp's Additional Paid In Capital amounts to 2.4B USD.
What is Edwards Lifesciences Corp's Additional Paid In Capital growth rate?
Additional Paid In Capital CAGR 10Y
13%
13%
Over the last year, the Additional Paid In Capital growth was 16%. The average annual Additional Paid In Capital growth rates for Edwards Lifesciences Corp have been 17% over the past three years , 10% over the past five years , and 13% over the past ten years .
You don't have any saved screeners yet
